2022年1期
刊物介紹
本刊主要是及時(shí)報(bào)道我國在腫瘤防治研究領(lǐng)域包括癌癥基礎(chǔ)理論研究和癌癥預(yù)防、臨床治療研究方面的新進(jìn)展、新成果，內(nèi)容涉及腫瘤病因?qū)W與滸病學(xué)，實(shí)驗(yàn)?zāi)[瘤學(xué)、腫瘤細(xì)胞分子生物學(xué)，腫瘤病理學(xué)以及腫瘤影像診斷、腫瘤外科治療、化學(xué)治療、放射治療、介入治療、生物治療和中西醫(yī)結(jié)合治療腫瘤等各分支學(xué)科，旨在促進(jìn)國內(nèi)外學(xué)術(shù)交流，提高我國癌癥研究與癌癥治療水平。
Chinese Journal of Cancer Research
Original Article
- Deregulated expression and subcellular localization of CPSF6, a circRNA-binding protein, promote malignant development of esophageal squamous cell carcinoma
- Equivalent efficacy assessment of QL1101 and bevacizumab in nonsquamous non-small cell lung cancer patients: A two-year follow-up data update
- Coupling radiomics analysis of CT image with diversification of tumor ecosystem: A new insight to overall survival in stage I-III colorectal cancer
- A durable 4-1BB-based CD19 CAR-T cell for treatment of relapsed or refractory non-Hodgkin lymphoma